Shanghai, China

Kuan Jiang

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Fudan University. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kuan Jiang. Retrieved from https://idiyas.com/inventor/kuan-jiang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Ocular Drug Delivery by Kuan Jiang

Introduction

Kuan Jiang is an accomplished inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical preparations, particularly in ocular drug delivery systems. With a total of two patents to his name, Jiang's work focuses on enhancing the bioavailability of drugs administered to the eye.

Latest Patents

Jiang's latest patents include "Polypeptide-based ocular absorption enhancer and application thereof" and "Polypeptide eye absorption enhancer and use thereof." Both patents relate to the design of lipophilic derivatives using the wild-type penetrating peptide, penetratin. These derivatives exhibit a strong ability to penetrate ocular tissues without causing toxicity. They serve as ocular absorption enhancers, allowing for non-invasive intraocular drug delivery and significantly increasing the ocular bioavailability of medications. The ophthalmic drug delivery systems developed from these penetratin derivatives are intended for eye drop administration, providing a more convenient and safer alternative to intraocular injections, which often face compliance issues among patients.

Career Highlights

Kuan Jiang is affiliated with Fudan University, where he continues to advance research in pharmaceutical innovations. His work has the potential to transform the treatment of intraocular and fundus diseases, enhancing patient compliance and safety.

Collaborations

Jiang collaborates with notable colleagues, including Gang Wei and Weiyue Lu, contributing to a dynamic research environment that fosters innovation in ocular drug delivery.

Conclusion

Kuan Jiang's contributions to ocular drug delivery through his innovative patents highlight the importance of non-invasive treatment options in enhancing patient care. His work at Fudan University continues to pave the way for advancements in pharmaceutical preparations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…